Research Index.
A continuously updated archive of research compounds. Source-based breakdowns, classified by domain.
Glutathione
Tripeptide of glutamate, cysteine, and glycine, the body's primary intracellular antioxidant studied for redox balance, detoxification, mitochondrial support, and cellular resilience.
LL-37
Human cathelicidin host-defense peptide studied for antimicrobial activity, anti-biofilm effects, epithelial barrier protection, immune modulation, and wound-repair biology.
MOTS-C
16 amino acid mitochondrial-derived peptide studied for energy metabolism, insulin sensitivity, AMPK signaling, exercise adaptation, and age-related metabolic resilience.
NAD+
Foundational cellular coenzyme studied for energy metabolism, mitochondrial function, DNA repair signaling, sirtuin activity, and age-associated cellular resilience.
SS-31
Mitochondria-targeted tetrapeptide (elamipretide) studied for cardiolipin binding, inner mitochondrial membrane support, ATP production, and oxidative stress resilience.
Epitalon
Synthetic AEDG tetrapeptide studied for telomerase activity, telomere maintenance, pineal peptide biology, and cellular aging pathways.
GHRP-6
Synthetic hexapeptide growth hormone secretagogue acting through the ghrelin receptor, studied for pituitary GH release, appetite signaling, and endocrine response.
IGF-1 LR3
Modified IGF-1 analog (Long R3) with reduced IGF-binding protein affinity, studied for IGF-1 receptor signaling, nutrient uptake, and tissue remodeling.
Sermorelin
Synthetic 29 amino acid GHRH analog studied for pituitary growth hormone release, endocrine signaling, and age-associated GH decline.
Tesamorelin
FDA-approved GHRH analog (EGRIFTA WR), studied for pituitary GH release and clinically used to reduce visceral abdominal fat in HIV-associated lipodystrophy.
Ipamorelin
Synthetic pentapeptide growth hormone secretagogue, selective GH release via the ghrelin receptor with less ACTH/cortisol response than older GHRPs.
Tesamorelin / Ipamorelin
Dual-pathway GH signaling blend pairing a GHRH analog (Tesamorelin) with a selective ghrelin-receptor secretagogue (Ipamorelin) for combined endogenous GH release research.
CJC-1295 No DAC / Ipamorelin
Dual-pathway GH signaling blend pairing a short-acting GHRH analog (CJC-1295 No DAC) with a selective ghrelin-receptor secretagogue (Ipamorelin) for pulse-oriented endogenous GH release research.
Thymosin Alpha-1
28 amino acid thymic peptide (thymalfasin) studied for immune regulation, T-cell and dendritic cell signaling, viral infection research, and immune-recovery biology.
VIP
Vasoactive Intestinal Peptide, a 28 amino acid neuroimmune signaling peptide studied for immune regulation, inflammatory balance, vascular tone, and gut-lung-immune communication.
KPV
Lysine-Proline-Valine tripeptide derived from alpha-MSH, studied for anti-inflammatory signaling, NF-kappaB modulation, gut and skin barrier biology, antimicrobial activity, and tissue-repair environments.
BPC-157
Body Protection Compound 157, a stable gastric pentadecapeptide studied for tissue repair, tendon/ligament healing models, GI protection, angiogenesis, and inflammation-recovery biology.
TB-500
Thymosin beta-4 related research peptide (Ac-LKKTETQ) studied for tissue repair, actin regulation, cell migration, angiogenesis, wound-healing biology, and recovery signaling.
BPC-157 / TB-500
Combined BPC-157 and TB-500 research blend studied for complementary tissue-repair signaling, inflammation modulation, angiogenesis, cell migration, and soft-tissue recovery biology.
5-Amino-1MQ
Small-molecule NNMT inhibitor studied for adipose-tissue energy metabolism, NAD+/SAM preservation, and body-composition research in preclinical obesity models.
AOD-9604
Synthetic C-terminal hGH fragment (modified 177-191) studied for lipolysis, anti-lipogenesis, and fat-metabolism research, generally well tolerated in human trials but did not reach obesity-drug efficacy.
Dual Regulator DIA-39-C20
Catalogue identifier for Tirzepatide, a dual GIP/GLP-1 receptor agonist with strong human clinical evidence for chronic weight management, type 2 diabetes, and obstructive sleep apnea in adults with obesity.
Single Regulator SIA-31-C18
Catalogue identifier for Semaglutide, a GLP-1 receptor agonist with strong human clinical evidence for appetite regulation, glycemic control, chronic weight management, and cardiovascular risk reduction.
Triple Regulator TIA-39-C20
Catalogue identifier for Retatrutide, an investigational triple GIP/GLP-1/glucagon receptor agonist with strong phase 2/3 data for body-weight reduction, glycemic control, MASLD, OSA, and obesity-related complications. Not FDA-approved.
SLU-PP-332
Synthetic pan-ERR (α/β/γ) agonist studied as an exercise-mimetic, preclinical evidence for mitochondrial function, fatty acid oxidation, endurance, and metabolic syndrome models. Investigational; published research notes limited oral bioavailability.
N-Acetyl Selank
Selank-related nootropic research peptide studied for calm focus, stress resilience, anxiety-related signaling, GABAergic modulation, and cognitive performance under stress.
N-Acetyl Semax
Acetylated Semax analogue studied for BDNF/TrkB signaling, neurotransmitter modulation, stress-response biology, and cognitive-resilience pathways.
Pinealon
EDR tripeptide (Glu-Asp-Arg) studied for neuroprotection, oxidative-stress regulation, memory-related signaling, and brain-cell resilience in cognitive-aging research.
Kisspeptin
Reproductive signaling peptide studied for sexual health, hormone signaling, fertility biology, and sexual desire pathways.
PT-141
Melanocortin receptor agonist studied for sexual desire, arousal signaling, and brain-driven sexual response.
GHK-Cu
Copper-binding tripeptide studied for skin remodeling, collagen and elastin support, wound-repair biology, and antioxidant signaling.
GHK Serum, 10% GHK & SNAP-8
Topical cosmetic peptide blend studied for skin remodeling, collagen and elastin support, and expression-line appearance.
GLOW
Research peptide blend of GHK-Cu, BPC-157, and TB-500 studied for skin remodeling, tissue repair signaling, and recovery-environment biology.
KLOW
Research peptide blend of GHK-Cu, BPC-157, TB-500, and KPV studied for skin remodeling, inflammation regulation, barrier support, and recovery signaling.
Melanotan I
Alpha-MSH analog (afamelanotide) studied for MC1R activation, eumelanin production, light tolerance, and photoprotection biology in erythropoietic protoporphyria research.
Melanotan II
Synthetic cyclic alpha-MSH analog and nonselective melanocortin receptor agonist studied for MC1R-driven pigmentation, sexual-response signaling, and neuroendocrine melanocortin pathways.
DSIP
Delta Sleep-Inducing Peptide studied for slow-wave sleep, sleep architecture, insomnia research, and nervous-system recovery signaling.